2D	Two-dimensional
3D	Three-dimensional
AIDS	Acquired immunodeficiency syndrome
ADP	Adenosine diphosphate
AKT	Protein kinase B
AMP	Adenosine monophosphate
AMPK	Activated protein kinase
ATP	Adenosine triphosphate
BRCA	Breast cancer
CI	Confidential interval
CSCs	Cancer stem cells
DNA	Deoxyribonucleic acid
EGFR	Epidermal growth factor receptor
EMT	Epithelial–mesenchymal transition
ERK	Extracellular signal-regulated kinases
HAART	Highly active anti-retroviral therapy
HGSC	High-grade serous carcinoma
HIV	Human immunodeficiency virus
HMGCR	3-Hydroxy-3-methylglutaryl-coenzyme A reductase
HR	Hazard ratio
iPARPs	PARP inhibitors
KPNB1	Karyopherin subunit beta 1
MDR	Multidrug resistance proteins
mTOR	Mammalian target of rapamycin
NF-κB	Nuclear factor kappa B
OC	Ovarian cancer
OD	Odds ratio
OS	Overall survival
P53/TP53	Tumour protein
PAK-1	P21–activated kinase
PARP	Poly (ADP-ribose) polymerase
PDX	Patient derived xenograft
PFS	Progression-free survival
PI3K	Phosphatidylinositol 3-kinases
SMAD2/3	Mothers against decapentaplegic homolog 2/3
RAS	Rat sarcoma virus
ROS	Reactive oxygen species
RR	Relative risk
TGF-β	Transforming growth factor beta
VEGF	Vascular endothelial growth factor
VEGFR2	Vascular endothelial growth factor receptor 2
Wnt/TCF	Wnt/T-cell factor
YAP1	Yes-associated protein 1